Fundraising FoxMultimmune
1 known investors
Find your way into Multimmune
Sign up to see every warm intro you have to Multimmune
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Multimmune team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
multimmune develops cancer diagnostics and therapeutics ("theranostics") based on membrane Hsp70, a molecule expressed across many cancer types. Its work spans therapeutic interventions, drug targeting strategies, diagnostic tools, and imaging platforms within precision oncology.
Investors · 1
Frequently asked questions
- What does Multimmune do?
- multimmune develops cancer diagnostics and therapeutics ("theranostics") based on membrane Hsp70, a molecule expressed across many cancer types. Its work spans therapeutic interventions, drug targeting strategies, diagnostic tools, and imaging platforms within precision oncology.
- Who are Multimmune's investors?
- Multimmune's investors include Bayern Kapital.